Faruque Riffat

The University of Sydney, Chris O’Brien Lifehouse

Papers

Total Citations

H-Index

About

Faruque Riffat is a leading head and neck surgeon whose research centers on optimizing treatment for oropharyngeal squamous cell carcinoma (OPSCC), particularly through the lens of minimally invasive surgery. His most impactful work directly compares transoral robotic surgery (TORS) against radiotherapy and chemoradiotherapy for small-volume and early-stage oropharyngeal cancers. A landmark 2016 study, cited 82 times, evaluates these competing modalities, addressing the rising incidence of HPV-associated OPSCC in younger patients. Riffat’s contributions are pivotal in defining when surgery can safely replace or reduce the need for adjuvant therapies. His 2022 cohort study on avoiding primary-site radiotherapy after TORS demonstrates a commitment to improving swallowing function and quality of life by de-escalating treatment. By challenging traditional protocols, Riffat’s research provides critical evidence for personalized, less morbid care. His work is essential reading for clinicians and researchers navigating the balance between oncologic control and functional preservation in head and neck oncology.